Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy of Intermittent Screening and Treatment or Intermittent Preventive Treatment (IPT) With Dihydroartemisinin-Piperaquine, Versus IPT With Sulfadoxine-Pyrimethamine for the Control of Malaria in Pregnancy in Kenya (STOP MiP KENYA)

This study is ongoing, but not recruiting participants.
Centers for Disease Control and Prevention
Liverpool School of Tropical Medicine
London School of Hygiene and Tropical Medicine
Information provided by (Responsible Party):
Abraham Katana, MD, Kenya Medical Research Institute Identifier:
First received: August 15, 2012
Last updated: August 5, 2015
Last verified: August 2015